NuWave Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$210K Buy
+2,541
New +$245K 0.24% 148
2021
Q4
Sell
-5,228
Closed -$592K 336
2021
Q3
$592K Buy
+5,228
New +$597K 0.68% 41
2021
Q2
Sell
-450
Closed -$38K 359
2021
Q1
$38K Buy
+450
New +$38K 0.05% 242
2020
Q4
Sell
-1,125
Closed -$90K 396
2020
Q3
$90K Buy
1,125
+430
+62% +$33.6K 0.14% 192
2020
Q2
$48K Buy
+695
New +$49.4K 0.06% 201
2020
Q1
Sell
-5,646
Closed -$439K 267
2019
Q4
$439K Buy
5,646
+1,566
+38% +$122K 0.43% 83
2019
Q3
$300K Sell
4,080
-6,450
-61% -$453K 0.3% 114
2019
Q2
$648K Buy
10,530
+6,261
+147% +$379K 0.68% 47
2019
Q1
$272K Buy
4,269
+3,228
+310% +$184K 0.32% 111
2018
Q4
$53K Sell
1,041
-5,196
-83% -$263K 0.09% 184
2018
Q3
$362K Sell
6,237
-7,185
-54% -$351K 0.55% 77
2018
Q2
$652K Buy
13,422
+12,054
+881% +$563K 0.85% 38
2018
Q1
$62K Sell
1,368
-348
-20% -$15.1K 0.1% 181
2017
Q4
$65K Buy
+1,716
New +$63K 0.08% 192
2014
Q3
$122K Buy
7,128
+6,756
+1,816% +$107K 0.35% 104
2014
Q2
$5K Sell
372
-756
-67% -$10.2K 0.01% 275
2014
Q1
$14K Buy
1,128
+558
+98% +$6.44K 0.04% 212
2013
Q4
$6K Buy
570
+330
+138% +$3.72K 0.01% 255
2013
Q3
$3K Sell
240
-114
-32% -$1.33K ﹤0.01% 295
2013
Q2
$4K Buy
+354
New +$4.19K ﹤0.01% 293

Other funds holding EW

NuWave Investment Management's EW Position: Q3 2022 in Review

NuWave Investment Management opened a new position in Edwards Lifesciences (EW) in Q3 2022: 2,541 shares worth $210K. The stake represents 0.24% of the portfolio and ranks #148 among its holdings. This is a return to the name: NuWave Investment Management previously reported a position in EW as recently as Q3 2021.

NuWave Investment Management first reported a position in EW in Q2 2013 and has held it in 20 quarters since. The position peaked at $652K in Q2 2018. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • NuWave Investment Management held 2,541 shares of Edwards Lifesciences worth $210K as of Q3 2022.
  • Edwards Lifesciences was a new NuWave Investment Management position in Q3 2022.
  • Edwards Lifesciences made up 0.24% of NuWave Investment Management's portfolio in Q3 2022, its #148 holding.
  • NuWave Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 20 quarters since.
  • NuWave Investment Management's Edwards Lifesciences position peaked at $652K in Q2 2018.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.